Loading Events

« All Events

  • This event has passed.

FULLY BOOKED – BioBriefing – Hot or Not: Trends for 2018

February 1, 2018 @ 4:00 pm - 6:00 pm AEDT

FULLY BOOKED – Our annual “Hot or Not” panel discussion will explore the global trends for the coming year with 4 speakers each presenting a short snapshot of what is HOT and what is NOT going into 2018.

2018 Topics and Speakers

– The growing medical marijuana market – Peter Crock, Chief Executive Officer, Cann Group

– Sector Investment Outlook – Dr Amanda Gillon, BioScience Managers, Investment Manager and Director of CHARM Informatics Pty Ltd & Rex Bionics Pty Ltd

– What we can expect to see in the DNA testing market – Sonia Gowan, Associate Director Marketing, Asia Pacific Japan, Illumina

– Blockchain and crypto-technology – Mark Williams, Senior Associate, Phillips Ormonde Fitzpatrick

Read more about these presenters below.

Date:                Thursday 1st February, 2018
Time:               4:00pm – 5:30pm followed by a networking session
Venue:             Philips Ormonde Fitzpatrick, Level 16, 333 Collins Street Melbourne


Members: $65
Non Members: $130
(Prices include GST)

To check if your organisation is a member, click here


Peter Crock, CEO, Cann Group

Peter is an experienced public company senior manager with deep knowledge and expertise in marketing and technology development. Since joining Cann Group in May 2016, Peter has reset the business plan as directed by the board and led the company through a successful initial public offering (IPO) to list on the Australian Securities Exchange (ASX), raising $13.5 million while bringing outstanding institutional and cornerstone investor support. This was followed by a subsequent $70m+ capital raising within the same year to accelerate the company’s expansion program.

Peter has also guided the company to a position at the forefront of Australia’s developing medicinal cannabis industry, it being the first company to receive the necessary licences and permits from the Office of Drug Control as well as producing Australia’s first commercial medicinal cannabis.

In a 28-year career at Nufarm (ASX:NUF) prior to joining Cann, Peter held senior management roles in marketing, business development, and information technology, heading up the group’s new technologies division which involved the licensing and commercial development of several new agribusiness technologies. He has project managed the successful integration of newly acquired businesses and has extensive experience working with regulators in Australia and overseas.

Dr Amanda Gillon,  BioScience Managers, Investment Manager

Amanda is an Investment Manager with BioScience Managers. With 5 years’ of life science specific investment experience she performs portfolio management, deal origination, prospective investment company due diligence and deal negotiation.

Prior to this role, Amanda’s research experience included a post-doctoral fellowship in protein trafficking disorders at Columbia University in New York, USA. She holds a PhD in Molecular Biology and Biochemistry from La Trobe University in Melbourne and an MBA from Melbourne Business School.

Amanda is currently a Director of: CHARM Informatics Pty Ltd & Rex Bionics Pty Ltd

 Sonia Gowan,  Associate Director Marketing, Asia Pacific Japan, Illumina

Sonia has over 20 years’ experience in life sciences both in the laboratory and in sales and marketing. She has worked for companies in New Zealand, United Kingdom, Singapore and Australia. Having held an Asia Pacific role for the past 10 years, Sonia is experienced in diverse market environments including different cultural, regulatory and market accessibility.

Sonia leads the Illumina marketing team and is working to ensure that genomic applications are widely understood and adopted. Today, Illumina is a global leader in genomics. We now have the ability to sequence at an unprecedented scale. While the rate of progress is accelerating exponentially, we are only just beginning to understand the clinical significance of the genome. These advances will trigger a fundamental shift in healthcare and beyond.

Mark Williams    Phillips Ormonde Fitzpatrick – Senior Associate

Mark’s academic background is in computer science and electrical engineering. He assists clients in obtaining and enforcing their intellectual property rights in the areas of software, electronics and engineering. Prior to joining Phillips Ormonde Fitzpatrick, Mark worked with a major Australian car manufacturer within their Current and Past Model Engineering group.

Mark has 15 years’ experience in patent practice in Australia. His professional practice focuses on drafting and prosecuting patent applications both in Australia and overseas. Mark focuses on a diverse range of inventions, including electronic devices, mining and mining hardware, software, computer implemented inventions and electronic gaming machine systems. Mark also assists clients in obtaining trade mark protection.

Hosted by:


February 1, 2018
4:00 pm - 6:00 pm
Event Category:


BioMelbourne Network
+61 3 9667 8181


Philips Ormonde Fitzpatrick
Level 16, 333 Collins Street
Melbourne, Vic 3000 Australia
+ Google Map


News & opinion

Member Directory